nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—AR—semen—acquired immunodeficiency syndrome	0.0348	0.163	CbGeAlD
Fludrocortisone—NR3C2—blood plasma—acquired immunodeficiency syndrome	0.0171	0.0801	CbGeAlD
Fludrocortisone—NR3C1—nerve—acquired immunodeficiency syndrome	0.0121	0.0568	CbGeAlD
Fludrocortisone—NR3C2—retina—acquired immunodeficiency syndrome	0.00937	0.0438	CbGeAlD
Fludrocortisone—NR3C1—blood plasma—acquired immunodeficiency syndrome	0.00918	0.0429	CbGeAlD
Fludrocortisone—NR3C2—digestive system—acquired immunodeficiency syndrome	0.00658	0.0308	CbGeAlD
Fludrocortisone—NR3C2—blood—acquired immunodeficiency syndrome	0.00627	0.0293	CbGeAlD
Fludrocortisone—AR—skin of body—acquired immunodeficiency syndrome	0.00609	0.0285	CbGeAlD
Fludrocortisone—NR3C2—spinal cord—acquired immunodeficiency syndrome	0.00604	0.0283	CbGeAlD
Fludrocortisone—NR3C2—vagina—acquired immunodeficiency syndrome	0.00581	0.0272	CbGeAlD
Fludrocortisone—Myopathy—Efavirenz—acquired immunodeficiency syndrome	0.00551	0.00701	CcSEcCtD
Fludrocortisone—NR3C2—lung—acquired immunodeficiency syndrome	0.0055	0.0257	CbGeAlD
Fludrocortisone—Diabetes mellitus—Amprenavir—acquired immunodeficiency syndrome	0.00534	0.00679	CcSEcCtD
Fludrocortisone—Glaucoma—Efavirenz—acquired immunodeficiency syndrome	0.00514	0.00653	CcSEcCtD
Fludrocortisone—NR3C2—nervous system—acquired immunodeficiency syndrome	0.00509	0.0238	CbGeAlD
Fludrocortisone—AR—lymphoid tissue—acquired immunodeficiency syndrome	0.00493	0.0231	CbGeAlD
Fludrocortisone—NR3C2—central nervous system—acquired immunodeficiency syndrome	0.0049	0.0229	CbGeAlD
Fludrocortisone—Myopathy—Ritonavir—acquired immunodeficiency syndrome	0.00488	0.00621	CcSEcCtD
Fludrocortisone—AR—digestive system—acquired immunodeficiency syndrome	0.00487	0.0228	CbGeAlD
Fludrocortisone—Diabetes mellitus—Didanosine—acquired immunodeficiency syndrome	0.00487	0.00619	CcSEcCtD
Fludrocortisone—Glycosuria—Efavirenz—acquired immunodeficiency syndrome	0.00477	0.00607	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Nevirapine—acquired immunodeficiency syndrome	0.00477	0.00606	CcSEcCtD
Fludrocortisone—Myopathy—Saquinavir—acquired immunodeficiency syndrome	0.0047	0.00597	CcSEcCtD
Fludrocortisone—AR—blood—acquired immunodeficiency syndrome	0.00464	0.0217	CbGeAlD
Fludrocortisone—Rash maculo-papular—Nelfinavir—acquired immunodeficiency syndrome	0.00462	0.00587	CcSEcCtD
Fludrocortisone—Petechiae—Delavirdine—acquired immunodeficiency syndrome	0.0045	0.00572	CcSEcCtD
Fludrocortisone—Myopathy—Lamivudine—acquired immunodeficiency syndrome	0.00448	0.0057	CcSEcCtD
Fludrocortisone—AR—spinal cord—acquired immunodeficiency syndrome	0.00447	0.0209	CbGeAlD
Fludrocortisone—NR3C1—skin of body—acquired immunodeficiency syndrome	0.00441	0.0206	CbGeAlD
Fludrocortisone—Anaphylactoid reaction—Didanosine—acquired immunodeficiency syndrome	0.00437	0.00556	CcSEcCtD
Fludrocortisone—AR—vagina—acquired immunodeficiency syndrome	0.0043	0.0201	CbGeAlD
Fludrocortisone—Contusion—Delavirdine—acquired immunodeficiency syndrome	0.00424	0.00539	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Nelfinavir—acquired immunodeficiency syndrome	0.00424	0.00539	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Stavudine—acquired immunodeficiency syndrome	0.00423	0.00537	CcSEcCtD
Fludrocortisone—Glycosuria—Ritonavir—acquired immunodeficiency syndrome	0.00422	0.00537	CcSEcCtD
Fludrocortisone—Amenorrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00421	0.00536	CcSEcCtD
Fludrocortisone—Fluid retention—Zidovudine—acquired immunodeficiency syndrome	0.00418	0.00531	CcSEcCtD
Fludrocortisone—AR—lung—acquired immunodeficiency syndrome	0.00407	0.019	CbGeAlD
Fludrocortisone—Injury—Nelfinavir—acquired immunodeficiency syndrome	0.00401	0.0051	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Zidovudine—acquired immunodeficiency syndrome	0.004	0.00509	CcSEcCtD
Fludrocortisone—Injury—Stavudine—acquired immunodeficiency syndrome	0.004	0.00509	CcSEcCtD
Fludrocortisone—NR3C2—brain—acquired immunodeficiency syndrome	0.00389	0.0182	CbGeAlD
Fludrocortisone—AR—nervous system—acquired immunodeficiency syndrome	0.00377	0.0176	CbGeAlD
Fludrocortisone—NR3C2—lymph node—acquired immunodeficiency syndrome	0.00376	0.0176	CbGeAlD
Fludrocortisone—AR—central nervous system—acquired immunodeficiency syndrome	0.00363	0.017	CbGeAlD
Fludrocortisone—Affect lability—Nelfinavir—acquired immunodeficiency syndrome	0.00363	0.00462	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Amprenavir—acquired immunodeficiency syndrome	0.00362	0.0046	CcSEcCtD
Fludrocortisone—Affect lability—Stavudine—acquired immunodeficiency syndrome	0.00362	0.0046	CcSEcCtD
Fludrocortisone—Pancreatitis—Didanosine—acquired immunodeficiency syndrome	0.00359	0.00456	CcSEcCtD
Fludrocortisone—NR3C1—lymphoid tissue—acquired immunodeficiency syndrome	0.00357	0.0167	CbGeAlD
Fludrocortisone—NR3C1—digestive system—acquired immunodeficiency syndrome	0.00353	0.0165	CbGeAlD
Fludrocortisone—Cardiac failure congestive—Zidovudine—acquired immunodeficiency syndrome	0.00352	0.00448	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Efavirenz—acquired immunodeficiency syndrome	0.00351	0.00447	CcSEcCtD
Fludrocortisone—Mood swings—Nelfinavir—acquired immunodeficiency syndrome	0.00349	0.00444	CcSEcCtD
Fludrocortisone—Mood swings—Stavudine—acquired immunodeficiency syndrome	0.00348	0.00443	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Indinavir—acquired immunodeficiency syndrome	0.00342	0.00434	CcSEcCtD
Fludrocortisone—Oesophagitis—Delavirdine—acquired immunodeficiency syndrome	0.00338	0.0043	CcSEcCtD
Fludrocortisone—NR3C1—blood—acquired immunodeficiency syndrome	0.00336	0.0157	CbGeAlD
Fludrocortisone—Rash maculo-papular—Delavirdine—acquired immunodeficiency syndrome	0.00336	0.00428	CcSEcCtD
Fludrocortisone—Ecchymosis—Delavirdine—acquired immunodeficiency syndrome	0.00335	0.00425	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Didanosine—acquired immunodeficiency syndrome	0.0033	0.0042	CcSEcCtD
Fludrocortisone—NR3C1—bone marrow—acquired immunodeficiency syndrome	0.00325	0.0152	CbGeAlD
Fludrocortisone—Muscular weakness—Nelfinavir—acquired immunodeficiency syndrome	0.00325	0.00414	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Efavirenz—acquired immunodeficiency syndrome	0.00324	0.00412	CcSEcCtD
Fludrocortisone—NR3C1—spinal cord—acquired immunodeficiency syndrome	0.00324	0.0152	CbGeAlD
Fludrocortisone—Pancreatitis—Nevirapine—acquired immunodeficiency syndrome	0.00323	0.0041	CcSEcCtD
Fludrocortisone—Abdominal distension—Nelfinavir—acquired immunodeficiency syndrome	0.00321	0.00408	CcSEcCtD
Fludrocortisone—Muscular weakness—Abacavir—acquired immunodeficiency syndrome	0.00319	0.00406	CcSEcCtD
Fludrocortisone—Affect lability—Zidovudine—acquired immunodeficiency syndrome	0.00314	0.004	CcSEcCtD
Fludrocortisone—Oesophagitis—Ritonavir—acquired immunodeficiency syndrome	0.00313	0.00398	CcSEcCtD
Fludrocortisone—Pancreatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00312	0.00397	CcSEcCtD
Fludrocortisone—NR3C1—vagina—acquired immunodeficiency syndrome	0.00312	0.0146	CbGeAlD
Fludrocortisone—Pancreatitis—Stavudine—acquired immunodeficiency syndrome	0.00311	0.00396	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Ritonavir—acquired immunodeficiency syndrome	0.00311	0.00396	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Efavirenz—acquired immunodeficiency syndrome	0.0031	0.00394	CcSEcCtD
Fludrocortisone—Ecchymosis—Ritonavir—acquired immunodeficiency syndrome	0.00309	0.00393	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Indinavir—acquired immunodeficiency syndrome	0.00307	0.0039	CcSEcCtD
Fludrocortisone—Pancreatitis—Abacavir—acquired immunodeficiency syndrome	0.00307	0.0039	CcSEcCtD
Fludrocortisone—Mood swings—Zidovudine—acquired immunodeficiency syndrome	0.00303	0.00385	CcSEcCtD
Fludrocortisone—Oesophagitis—Saquinavir—acquired immunodeficiency syndrome	0.00301	0.00383	CcSEcCtD
Fludrocortisone—Vascular purpura—Delavirdine—acquired immunodeficiency syndrome	0.003	0.00382	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Saquinavir—acquired immunodeficiency syndrome	0.00299	0.00381	CcSEcCtD
Fludrocortisone—Neoplasm—Saquinavir—acquired immunodeficiency syndrome	0.00298	0.00379	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Nevirapine—acquired immunodeficiency syndrome	0.00297	0.00377	CcSEcCtD
Fludrocortisone—NR3C1—lung—acquired immunodeficiency syndrome	0.00295	0.0138	CbGeAlD
Fludrocortisone—Injury—Delavirdine—acquired immunodeficiency syndrome	0.00292	0.00372	CcSEcCtD
Fludrocortisone—AR—brain—acquired immunodeficiency syndrome	0.00288	0.0135	CbGeAlD
Fludrocortisone—Hyperglycaemia—Nelfinavir—acquired immunodeficiency syndrome	0.00287	0.00366	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Stavudine—acquired immunodeficiency syndrome	0.00287	0.00364	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Ritonavir—acquired immunodeficiency syndrome	0.00286	0.00363	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Abacavir—acquired immunodeficiency syndrome	0.00282	0.00359	CcSEcCtD
Fludrocortisone—Purpura—Delavirdine—acquired immunodeficiency syndrome	0.00279	0.00354	CcSEcCtD
Fludrocortisone—AR—lymph node—acquired immunodeficiency syndrome	0.00278	0.013	CbGeAlD
Fludrocortisone—Affect lability—Efavirenz—acquired immunodeficiency syndrome	0.00276	0.00351	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Saquinavir—acquired immunodeficiency syndrome	0.00276	0.00351	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Saquinavir—acquired immunodeficiency syndrome	0.00275	0.0035	CcSEcCtD
Fludrocortisone—NR3C1—nervous system—acquired immunodeficiency syndrome	0.00273	0.0128	CbGeAlD
Fludrocortisone—Pancreatitis—Zidovudine—acquired immunodeficiency syndrome	0.00271	0.00344	CcSEcCtD
Fludrocortisone—Injury—Ritonavir—acquired immunodeficiency syndrome	0.0027	0.00344	CcSEcCtD
Fludrocortisone—Sweating increased—Zidovudine—acquired immunodeficiency syndrome	0.00269	0.00342	CcSEcCtD
Fludrocortisone—Mood swings—Efavirenz—acquired immunodeficiency syndrome	0.00266	0.00338	CcSEcCtD
Fludrocortisone—Affect lability—Delavirdine—acquired immunodeficiency syndrome	0.00264	0.00336	CcSEcCtD
Fludrocortisone—NR3C1—central nervous system—acquired immunodeficiency syndrome	0.00263	0.0123	CbGeAlD
Fludrocortisone—Muscular weakness—Indinavir—acquired immunodeficiency syndrome	0.00262	0.00333	CcSEcCtD
Fludrocortisone—Injury—Saquinavir—acquired immunodeficiency syndrome	0.0026	0.00331	CcSEcCtD
Fludrocortisone—Abdominal distension—Indinavir—acquired immunodeficiency syndrome	0.00258	0.00329	CcSEcCtD
Fludrocortisone—Haemoglobin—Nelfinavir—acquired immunodeficiency syndrome	0.00256	0.00326	CcSEcCtD
Fludrocortisone—Haemorrhage—Nelfinavir—acquired immunodeficiency syndrome	0.00255	0.00324	CcSEcCtD
Fludrocortisone—Mood swings—Delavirdine—acquired immunodeficiency syndrome	0.00254	0.00324	CcSEcCtD
Fludrocortisone—Pancreatitis—Indinavir—acquired immunodeficiency syndrome	0.00252	0.0032	CcSEcCtD
Fludrocortisone—Injury—Lamivudine—acquired immunodeficiency syndrome	0.00248	0.00316	CcSEcCtD
Fludrocortisone—Muscular weakness—Efavirenz—acquired immunodeficiency syndrome	0.00248	0.00315	CcSEcCtD
Fludrocortisone—Affect lability—Ritonavir—acquired immunodeficiency syndrome	0.00244	0.00311	CcSEcCtD
Fludrocortisone—Abdominal distension—Efavirenz—acquired immunodeficiency syndrome	0.00244	0.00311	CcSEcCtD
Fludrocortisone—Myalgia—Amprenavir—acquired immunodeficiency syndrome	0.00238	0.00303	CcSEcCtD
Fludrocortisone—Pancreatitis—Efavirenz—acquired immunodeficiency syndrome	0.00238	0.00303	CcSEcCtD
Fludrocortisone—Muscular weakness—Delavirdine—acquired immunodeficiency syndrome	0.00237	0.00301	CcSEcCtD
Fludrocortisone—Sweating increased—Efavirenz—acquired immunodeficiency syndrome	0.00236	0.00301	CcSEcCtD
Fludrocortisone—Mood swings—Ritonavir—acquired immunodeficiency syndrome	0.00235	0.00299	CcSEcCtD
Fludrocortisone—Abdominal distension—Delavirdine—acquired immunodeficiency syndrome	0.00234	0.00297	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Indinavir—acquired immunodeficiency syndrome	0.00232	0.00295	CcSEcCtD
Fludrocortisone—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.00229	0.00292	CcSEcCtD
Fludrocortisone—Pancreatitis—Delavirdine—acquired immunodeficiency syndrome	0.00228	0.00289	CcSEcCtD
Fludrocortisone—Sweating increased—Delavirdine—acquired immunodeficiency syndrome	0.00226	0.00288	CcSEcCtD
Fludrocortisone—Affect lability—Lamivudine—acquired immunodeficiency syndrome	0.00224	0.00285	CcSEcCtD
Fludrocortisone—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.00222	0.00282	CcSEcCtD
Fludrocortisone—Muscular weakness—Ritonavir—acquired immunodeficiency syndrome	0.00219	0.00279	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Efavirenz—acquired immunodeficiency syndrome	0.00219	0.00278	CcSEcCtD
Fludrocortisone—Myalgia—Didanosine—acquired immunodeficiency syndrome	0.00217	0.00276	CcSEcCtD
Fludrocortisone—Abdominal distension—Ritonavir—acquired immunodeficiency syndrome	0.00216	0.00275	CcSEcCtD
Fludrocortisone—Mood swings—Lamivudine—acquired immunodeficiency syndrome	0.00216	0.00275	CcSEcCtD
Fludrocortisone—Muscular weakness—Saquinavir—acquired immunodeficiency syndrome	0.00211	0.00268	CcSEcCtD
Fludrocortisone—Pancreatitis—Ritonavir—acquired immunodeficiency syndrome	0.0021	0.00268	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Delavirdine—acquired immunodeficiency syndrome	0.00209	0.00266	CcSEcCtD
Fludrocortisone—NR3C1—brain—acquired immunodeficiency syndrome	0.00209	0.00976	CbGeAlD
Fludrocortisone—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00208	0.00265	CcSEcCtD
Fludrocortisone—Abdominal distension—Saquinavir—acquired immunodeficiency syndrome	0.00208	0.00265	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Amprenavir—acquired immunodeficiency syndrome	0.00208	0.00264	CcSEcCtD
Fludrocortisone—Infection—Didanosine—acquired immunodeficiency syndrome	0.00207	0.00263	CcSEcCtD
Fludrocortisone—Haemoglobin—Indinavir—acquired immunodeficiency syndrome	0.00207	0.00263	CcSEcCtD
Fludrocortisone—Haemorrhage—Indinavir—acquired immunodeficiency syndrome	0.00206	0.00261	CcSEcCtD
Fludrocortisone—Pancreatitis—Saquinavir—acquired immunodeficiency syndrome	0.00203	0.00258	CcSEcCtD
Fludrocortisone—NR3C1—lymph node—acquired immunodeficiency syndrome	0.00202	0.00943	CbGeAlD
Fludrocortisone—Sweating increased—Saquinavir—acquired immunodeficiency syndrome	0.00201	0.00256	CcSEcCtD
Fludrocortisone—Muscular weakness—Lamivudine—acquired immunodeficiency syndrome	0.00201	0.00256	CcSEcCtD
Fludrocortisone—Abdominal distension—Lamivudine—acquired immunodeficiency syndrome	0.00198	0.00252	CcSEcCtD
Fludrocortisone—Vertigo—Abacavir—acquired immunodeficiency syndrome	0.00196	0.00249	CcSEcCtD
Fludrocortisone—Myalgia—Nevirapine—acquired immunodeficiency syndrome	0.00195	0.00248	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Ritonavir—acquired immunodeficiency syndrome	0.00194	0.00246	CcSEcCtD
Fludrocortisone—Pancreatitis—Lamivudine—acquired immunodeficiency syndrome	0.00193	0.00246	CcSEcCtD
Fludrocortisone—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.00192	0.00245	CcSEcCtD
Fludrocortisone—Convulsion—Nelfinavir—acquired immunodeficiency syndrome	0.00192	0.00245	CcSEcCtD
Fludrocortisone—Sweating increased—Lamivudine—acquired immunodeficiency syndrome	0.00192	0.00244	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Didanosine—acquired immunodeficiency syndrome	0.0019	0.00241	CcSEcCtD
Fludrocortisone—Myalgia—Nelfinavir—acquired immunodeficiency syndrome	0.00189	0.0024	CcSEcCtD
Fludrocortisone—Convulsion—Abacavir—acquired immunodeficiency syndrome	0.00189	0.0024	CcSEcCtD
Fludrocortisone—Myalgia—Stavudine—acquired immunodeficiency syndrome	0.00188	0.0024	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00187	0.00238	CcSEcCtD
Fludrocortisone—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.00187	0.00238	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Saquinavir—acquired immunodeficiency syndrome	0.00186	0.00237	CcSEcCtD
Fludrocortisone—Myalgia—Abacavir—acquired immunodeficiency syndrome	0.00186	0.00236	CcSEcCtD
Fludrocortisone—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.00181	0.0023	CcSEcCtD
Fludrocortisone—Oedema—Abacavir—acquired immunodeficiency syndrome	0.00178	0.00226	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00178	0.00226	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Lamivudine—acquired immunodeficiency syndrome	0.00178	0.00226	CcSEcCtD
Fludrocortisone—Infection—Abacavir—acquired immunodeficiency syndrome	0.00177	0.00225	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.00175	0.00223	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.00175	0.00222	CcSEcCtD
Fludrocortisone—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.00173	0.0022	CcSEcCtD
Fludrocortisone—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.00173	0.0022	CcSEcCtD
Fludrocortisone—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.00172	0.00219	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.0017	0.00217	CcSEcCtD
Fludrocortisone—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.00169	0.00215	CcSEcCtD
Fludrocortisone—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.00167	0.00212	CcSEcCtD
Fludrocortisone—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.00166	0.00211	CcSEcCtD
Fludrocortisone—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.00165	0.0021	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00165	0.0021	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.00165	0.00209	CcSEcCtD
Fludrocortisone—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.00164	0.00208	CcSEcCtD
Fludrocortisone—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.00164	0.00208	CcSEcCtD
Fludrocortisone—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00164	0.00208	CcSEcCtD
Fludrocortisone—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.00163	0.00208	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00162	0.00206	CcSEcCtD
Fludrocortisone—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.00162	0.00206	CcSEcCtD
Fludrocortisone—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.00161	0.00205	CcSEcCtD
Fludrocortisone—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.00161	0.00204	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00157	0.002	CcSEcCtD
Fludrocortisone—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00157	0.002	CcSEcCtD
Fludrocortisone—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00153	0.00195	CcSEcCtD
Fludrocortisone—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.00152	0.00194	CcSEcCtD
Fludrocortisone—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.00152	0.00193	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00152	0.00193	CcSEcCtD
Fludrocortisone—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00149	0.0019	CcSEcCtD
Fludrocortisone—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00149	0.00189	CcSEcCtD
Fludrocortisone—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00146	0.00186	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00146	0.00186	CcSEcCtD
Fludrocortisone—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00146	0.00186	CcSEcCtD
Fludrocortisone—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00146	0.00186	CcSEcCtD
Fludrocortisone—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.00145	0.00185	CcSEcCtD
Fludrocortisone—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00144	0.00183	CcSEcCtD
Fludrocortisone—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00144	0.00183	CcSEcCtD
Fludrocortisone—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.00144	0.00183	CcSEcCtD
Fludrocortisone—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00144	0.00183	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00143	0.00182	CcSEcCtD
Fludrocortisone—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00143	0.00182	CcSEcCtD
Fludrocortisone—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00142	0.00181	CcSEcCtD
Fludrocortisone—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00141	0.0018	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00141	0.0018	CcSEcCtD
Fludrocortisone—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.0014	0.00178	CcSEcCtD
Fludrocortisone—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00138	0.00175	CcSEcCtD
Fludrocortisone—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.00138	0.00175	CcSEcCtD
Fludrocortisone—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00137	0.00175	CcSEcCtD
Fludrocortisone—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.00134	0.00171	CcSEcCtD
Fludrocortisone—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00134	0.00171	CcSEcCtD
Fludrocortisone—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00133	0.0017	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00133	0.0017	CcSEcCtD
Fludrocortisone—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00133	0.00169	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00133	0.00169	CcSEcCtD
Fludrocortisone—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00132	0.00168	CcSEcCtD
Fludrocortisone—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00132	0.00168	CcSEcCtD
Fludrocortisone—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00131	0.00167	CcSEcCtD
Fludrocortisone—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00131	0.00167	CcSEcCtD
Fludrocortisone—Headache—Didanosine—acquired immunodeficiency syndrome	0.0013	0.00166	CcSEcCtD
Fludrocortisone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.0013	0.00165	CcSEcCtD
Fludrocortisone—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.0013	0.00165	CcSEcCtD
Fludrocortisone—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.0013	0.00165	CcSEcCtD
Fludrocortisone—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00129	0.00164	CcSEcCtD
Fludrocortisone—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00129	0.00164	CcSEcCtD
Fludrocortisone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00128	0.00162	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00128	0.00162	CcSEcCtD
Fludrocortisone—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00127	0.00162	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00126	0.0016	CcSEcCtD
Fludrocortisone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00125	0.00159	CcSEcCtD
Fludrocortisone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00125	0.00159	CcSEcCtD
Fludrocortisone—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00125	0.00159	CcSEcCtD
Fludrocortisone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00124	0.00158	CcSEcCtD
Fludrocortisone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00123	0.00157	CcSEcCtD
Fludrocortisone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00123	0.00156	CcSEcCtD
Fludrocortisone—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00122	0.00155	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.0012	0.00153	CcSEcCtD
Fludrocortisone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00119	0.00152	CcSEcCtD
Fludrocortisone—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00119	0.00151	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00118	0.0015	CcSEcCtD
Fludrocortisone—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00117	0.00149	CcSEcCtD
Fludrocortisone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00117	0.00149	CcSEcCtD
Fludrocortisone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00117	0.00149	CcSEcCtD
Fludrocortisone—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00117	0.00148	CcSEcCtD
Fludrocortisone—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00116	0.00148	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00114	0.00144	CcSEcCtD
Fludrocortisone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00114	0.00144	CcSEcCtD
Fludrocortisone—Headache—Stavudine—acquired immunodeficiency syndrome	0.00113	0.00144	CcSEcCtD
Fludrocortisone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00113	0.00143	CcSEcCtD
Fludrocortisone—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00112	0.00143	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00112	0.00143	CcSEcCtD
Fludrocortisone—Headache—Abacavir—acquired immunodeficiency syndrome	0.00111	0.00142	CcSEcCtD
Fludrocortisone—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00111	0.00142	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00111	0.00141	CcSEcCtD
Fludrocortisone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.0011	0.0014	CcSEcCtD
Fludrocortisone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.0011	0.00139	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00108	0.00138	CcSEcCtD
Fludrocortisone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00108	0.00137	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.00136	CcSEcCtD
Fludrocortisone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00106	0.00135	CcSEcCtD
Fludrocortisone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00105	0.00133	CcSEcCtD
Fludrocortisone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00105	0.00133	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.0013	CcSEcCtD
Fludrocortisone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00102	0.00129	CcSEcCtD
Fludrocortisone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.00129	CcSEcCtD
Fludrocortisone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00099	0.00126	CcSEcCtD
Fludrocortisone—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000984	0.00125	CcSEcCtD
Fludrocortisone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000973	0.00124	CcSEcCtD
Fludrocortisone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00097	0.00123	CcSEcCtD
Fludrocortisone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000947	0.0012	CcSEcCtD
Fludrocortisone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000933	0.00119	CcSEcCtD
Fludrocortisone—Headache—Indinavir—acquired immunodeficiency syndrome	0.000915	0.00116	CcSEcCtD
Fludrocortisone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000899	0.00114	CcSEcCtD
Fludrocortisone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00089	0.00113	CcSEcCtD
Fludrocortisone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000876	0.00111	CcSEcCtD
Fludrocortisone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000866	0.0011	CcSEcCtD
Fludrocortisone—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000864	0.0011	CcSEcCtD
Fludrocortisone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000843	0.00107	CcSEcCtD
Fludrocortisone—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000827	0.00105	CcSEcCtD
Fludrocortisone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000826	0.00105	CcSEcCtD
Fludrocortisone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000804	0.00102	CcSEcCtD
Fludrocortisone—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000765	0.000973	CcSEcCtD
Fludrocortisone—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000736	0.000936	CcSEcCtD
Fludrocortisone—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000702	0.000893	CcSEcCtD
